Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Peptide candidates for the development of therapeutics and vaccines against β-coronavirus infection.

Bioengineered - 1 Apr 2022

Chourasia Rounak, Padhi Srichandan, Phukon Loreni Chiring, Abedin Md Minhajul, Sirohi Ranjana, Singh Sudhir P, Rai Amit Kumar

Abstract excerpt

Betacoronaviruses (β-CoVs) have caused major viral outbreaks in the last two decades in the world. The mutation and recombination abilities in β-CoVs resulted in zoonotic diseases in humans. Proteins responsible for viral attachment and replication are highly conserved in β-CoVs. These conserved proteins have been extensively studied as targets for preventing infection and the spread of β-CoVs. Peptides are among...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiviral Agents
Share to Coronavirus Infections

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Mutation

Share to Peptides

Share to Vaccines

Source

Open in PubMed Open full text

Identifiers

PMID: 35387556
DOI: 10.1080/21655979.2022.2060453
PMCID: PMC9161909

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Peptide candidates for the development of therapeutics and vaccines against β-coronavirus infection.PMID 35387556Read ↗

Design of a peptide-based subunit vaccine against novel coronavirus SARS-CoV-2Semantic proximity Read ↗

Potential Immunogenic Activity of Computationally Designed mRNA- and Peptide-Based Prophylactic Vaccines against MERS, SARS-CoV, and SARS-CoV-2: A Reverse Vaccinology ApproachSemantic proximity Read ↗

An Overview of Antiviral Peptides and Rational Biodesign ConsiderationsSemantic proximity Read ↗

Synthetic peptide vaccinesSemantic proximity Read ↗

Peptides Based Vaccine Against SARS-nCoV-2 Antigenic Fragmented Synthetic Epitopes Recognized by T-Cell and β-Cell initiate Specific Antibody to Fight the InfectionSemantic proximity Read ↗

Milk Peptides as Novel Multi‐Targeted Therapeutic Candidates for SARS-CoV2Semantic proximity Read ↗

Screening Peptide Drug Candidates to Neutralize Whole Viral Agents : A Case study with SARS-CoV-2 VirusSemantic proximity Read ↗

Developing an Effective Peptide-Based Vaccine for COVID-19: Preliminary Studies in Mice ModelsSemantic proximity Read ↗

Probiotics-Derived Peptides and Their Immunomodulatory Molecules Can Play a Preventive Role Against Viral Diseases Including COVID-19Semantic proximity Read ↗

Immunoinformatics-Aided Design and In Vivo Validation of a Peptide-Based Multiepitope Vaccine Targeting Canine CircovirusSemantic proximity Read ↗

Innovative Strategies and Methodologies in Antimicrobial Peptide DesignSemantic proximity Read ↗

Milk Derived Antimicrobial Bioactive Peptides: A ReviewSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.